PMID: 8608941Apr 15, 1996Paper

A reversible, p53-dependent G0/G1 cell cycle arrest induced by ribonucleotide depletion in the absence of detectable DNA damage

Genes & Development
S P LinkeG M Wahl

Abstract

Cells with a functional p53 pathway undergo a G0/G1 arrest or apoptosis when treated with gamma radiation or many chemotherapeutic drugs. It has been proposed that DNA damage is the exclusive signal that triggers the arrest response. However, we found that certain ribonucleotide biosynthesis inhibitors caused a p53-dependent G0 or early G1 arrest in the absence of replicative DNA synthesis or detectable DNA damage in normal human fibroblasts. CTP, GTP, or UTP depletion alone was sufficient to induce arrest. In contrast to the p53-dependent response to DNA damage, characterized by long-term arrest and irregular cellular morphologies, the antimetabolite-induced arrest was highly reversible and cellular morphologies remained relatively normal. Both arrest responses correlated with prolonged induction of p53 and the Cdk inhibitor P21(WAF1/CIP1/SDI1) and with dephosphorylation of pRb. Thus, we propose that p53 can serve as a metabolite sensor activated by depletion of ribonucleotides or products or processes dependent on ribonucleotides. Accordingly, p53 may play a role in inducing a quiescence-like arrest state in response to nutrient challenge and a senescence-like arrest state in response to DNA damage. These results have importa...Continue Reading

References

Nov 1, 1979·Proceedings of the National Academy of Sciences of the United States of America·R G MoranC Heidelberger
Apr 1, 1976·Journal of Medical Genetics·J R Savage
Aug 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·S J KuerbitzM B Kastan
Jul 5, 1991·Science·M HollsteinC C Harris
Mar 1, 1968·Biochemical Pharmacology·G R Gale, G B Schmidt
Nov 1, 1982·Analytical Biochemistry·A L Pogolotti, D V Santi
Oct 24, 1995·Proceedings of the National Academy of Sciences of the United States of America·W LiJ R Bertino
Mar 1, 1993·Mutation Research·A Di LeonardoA Maddalena
Apr 11, 1995·Proceedings of the National Academy of Sciences of the United States of America·Y IshizakaG R Stark
Jun 6, 1995·Proceedings of the National Academy of Sciences of the United States of America·A AlmasanG M Wahl
Feb 3, 1995·The Journal of Biological Chemistry·S JayadevY A Hannun
Feb 28, 1995·Proceedings of the National Academy of Sciences of the United States of America·G S DbaiboY A Hannun
Jan 1, 1993·Cold Spring Harbor Symposia on Quantitative Biology·A Di LeonardoG M Wahl
Dec 16, 1993·Nature·Y XiongD Beach
Apr 1, 1993·Current Opinion in Cell Biology·K Nasmyth

❮ Previous
Next ❯

Citations

Dec 16, 1997·International Journal of Cancer. Journal International Du Cancer·D G PalmerA C Williams
Jul 19, 2008·Biotechnology and Bioengineering·M FusseneggerJ E Bailey
Aug 1, 1996·BioEssays : News and Reviews in Molecular, Cellular and Developmental Biology·M B Kastan
Jan 13, 1998·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·L YinS Sell
Feb 22, 2002·International Journal of Cancer. Journal International Du Cancer·Mikhail V Blagosklonny
Jun 17, 2005·Journal of Physiology and Biochemistry·M Gomez-LazaroJ Jordán
Jul 18, 2001·Springer Seminars in Immunopathology·N Fathy, D E Furst
Jan 25, 2008·Lasers in Medical Science·I L ZunguH Abrahamse
Jan 20, 2004·Pharmacology & Therapeutics·Zodwa DlaminiMakhosazana Zungu
Dec 22, 1999·Biochemical Pharmacology·C MéplanP Hainaut
Jul 31, 2003·Life Sciences·Hilde E van GijsselJohn H N Meerman
Aug 5, 1998·Pharmacology & Therapeutics·M Scheffner
Jan 1, 1997·Ultrasound in Medicine & Biology·G J CzarnotaJ W Hunt
Oct 25, 2001·Cancer Letters·O Pluquet, P Hainaut
Sep 21, 2002·Biochimica Et Biophysica Acta·Nghia T V Le, Des R Richardson
Apr 29, 1998·General Pharmacology·A R Kinsella, D Smith
Jan 23, 1999·Current Opinion in Cell Biology·T P Neufeld, B A Edgar
Jun 4, 1998·Current Opinion in Genetics & Development·T Weinert
May 9, 2003·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·S Lain, D Lane
Sep 29, 2001·Drug Discovery Today·J R. Lamb
May 7, 2013·Cell Death and Differentiation·M J ParsonsD R Green
Sep 1, 1997·Nature Medicine·T WaldmanJ Williams
Nov 26, 2009·Nature Reviews. Cancer·Christopher J BrownDavid P Lane
Jun 23, 1999·The Biochemical Journal·Q HuangT J Monks
Nov 4, 2000·The Biochemical Journal·T R HuppK L Ball
Apr 25, 2008·Proceedings of the National Academy of Sciences of the United States of America·Kedar HastakMunna L Agarwal
Jun 23, 2010·Proceedings of the National Academy of Sciences of the United States of America·Anastasia A KhutornenkoAlexandra G Evstafieva
Jan 15, 2005·Antioxidants & Redox Signaling·Michael A O'Reilly

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis